Abstract Fear of recurrence (FoR) is the most frequent concern patients wish to discuss in head and neck review clinics. The aim of the study was to design a simple screening question on fear of recurrence to be incorporated into the University of Washington Quality of Life Questionnaire (UW-QOLv4), for use in clinical practice. A cross-sectional survey comprising 528 patients was conducted. 11 % selected the two most severe FoR categories. FoR responses correlated strongly (Spearman r s = -0.82) with the mean score of the seven items of the Fear of Recurrence Questionnaire. There was also a strong association with anxiety and mood dysfunction as measured from the UW-QOL, and with overall QOL. Patients more affected by FoR tended to be younger and postradiotherapy or chemotherapy. The FoR screening question may be a useful addition to the UW-QOLv4 to help identify patients with significant FoR to receive extra support.
Introduction
One of the main emotional aspects for cancer survivors is the anxiety related to fear of the cancer coming back. Fear of recurrence (FoR) is described as 'the fear associated with the possibility the cancer will return or progress in the same or another part of the body' [1] . Fear of recurrence is a significant psychological problem and rates of up to 65 % have been reported [2] . It is the most frequent issue patients wish to raise in review consultations [3, 4] . This is not unexpected as patients face considerable uncertainty and daily challenges of living with and beyond head and neck cancer (HNC) [5] . Although FoR is a complex issue influenced by a multitude of factors, including demographic, clinical and psychological factors [2] , there is a body of consistent evidence developing in the literature specific to HNC [5] [6] [7] [8] [9] [10] [11] .
It is understandable that patients feel anxious about FoR and this can be considered entirely normal. However, sometimes the intensity of this specific anxiety can develop into a clinical-related problem with a set of characteristic symptoms such as ruminative worry, poor concentration, depressed mood, lack of future planning and poor quality of life. A self-regulation model consisting of psychological controls on thoughts and emotions has been developed to help explain this anxiety response in patients. It is a parallel process model divided into three sections: illness representations or concerns, emotional reactions, coping behaviours and an appraisal of the success of this coping [11] . The degree of success of the patient's coping is appraised and fed back to change the illness representations. The beliefs of the patient with high fears of recurrence are such that they frequently interpret everyday changes in bodily symptoms as a sign of serious disease. They then develop concern for their health and fear serious illness and their own demise; this can be very intrusive in the patient's life and contributes to their reports of inability to concentrate. These responses in the form of thoughts and unpleasant emotions then lead consequentially to behaviours such as reassurance-seeking, increased medical consultations and health-care costs [12, 13] . Anxiety can therefore have an effect on provisions of care in cancer, as those who have a high anxiety require greater assistance and consume more health-care resources. There has also been evidence to suggest that FoR in patients does not diminish over time and so is an ongoing burden for some patients [1, 5] .
It is difficult to predict which patients will experience FoR as it does not seem to relate to routine patient characteristics, such as stage and site of disease [5] . The Patient Concerns Inventory (PCI) gives the opportunity for FoR to be discussed in consultations as prompted by the patient [3, 4] . This patient-centred approach facilitates the discussion of the emotional aspects of cancer [14] . However with the PCI, there is no is no measure of severity to allow a focus on patients with more significant problems. For these patients, signposting for additional emotional support could be appropriate as could consideration of specific FoR interventions [15] . To screen for FoR there are several questionnaires available [17, 18] . However, for simplicity in clinical care it would be very useful to have a single question that could be added to an existing health-related quality of life questionnaire such as the University of Washington questionnaire (UW-QOLv4) [19] . The UW-QOL is a commonly used head and neck cancer-specific HRQOL questionnaire. Mood and anxiety were added to the original questionnaire [19] and there is merit in adding an item about FoR. There have been suggested single items for FoR [16, 18] . Our interest was to explore with patients and design an item that encapsulates their views of what constitutes their concern about a cancer recurrence following primary head and neck cancer treatment. We were also motivated to create wording that would fit into the UW-QOL format and scoring system. Hence, the aim of this study is to provide an individual question to assess FoR in the style of the UW-QOL. This can be added to the UW-QOL to help identify those patients with levels of FoR who might benefit from intervention.
Methods
The University Hospital Aintree database was used to access the records of patients treated for primary head and neck squamous cell carcinomas between 2008 and 2012. This gave a cohort of 1545 patients. These patients were analysed to see if they were currently alive or dead using both the hospital Sigma system and ONS data. Of the remaining patients, those aged over 85 years were excluded from the postal survey as were any patients treated with palliative intent or active recurrence, with cognitive impairment or living overseas and those from previous surveys having volunteered a wish not to receive any more questionnaires. Approval for the survey was given by Aintree University Hospital Clinical Audit Department.
The new UW-QOL style FoR question ( Fig. 1 ) was designed in several steps. The authors formulated the initial wording. This was then discussed on two separate occasions with patients at both the units Head and Neck Cancer Support Group and also a Head and Neck Cancer Research Forum. These groups comprise about 30 and 10 participants, respectively, on both instances. Patients were asked to comment on the wording, suggest changes and put forward ideas about the response categories. Changes were made and emailed to the support group including those unable to attend the meetings, and also the two head and neck clinical nurse specialists and our emotional support therapist. The final version was lastly e-mailed to the group again.
The UW-QOL is scored on two subscales: physical and socio-emotional function [19] . The physical function is scored as an average of questions based on swallowing, chewing, speech, saliva, taste and appearance, whilst socioemotional function is the average of activity, recreation, pain, mood, anxiety and shoulder. Criteria derived from earlier work [20] can indicate the domains in which patients have a significant problem or dysfunction, with these Fear of the cancer coming back (Tick one box ):
I have no fear of recurrence I have a liƩle fear, with occasional thoughts but they don't really bother me I am someƟmes having fearful thoughts but I can usually manage these I get a lot of fears of recurrence and these can really preoccupy my thoughts I am fearful all the Ɵme that my cancer might return and I struggle with this criteria being based on a mix of domain scores and domain importance over the past week. There is also a single-item overall QOL question for which patients are asked to consider not only physical and mental health, but also other factors, such as family, friends, spirituality or personal leisure activities important to their enjoyment of life. The survey package included the UW-QOL version 4, the new FoR screening question and also a 7-item 'Fear of Recurrence questionnaire' [1, 16] suitable for evaluating FoR in the outpatient setting. The seven questions consisted of statements with a five-point response scale (not at all, a little, sometimes, a lot, all the time). This was included to enable comparison of the FoR screening question with the more detailed FoR-specific questionnaire previously reported.
Survey packs containing a free return envelope, the survey, a cover letter and support group information were mailed on 28 February 2014. A reminder pack was sent to non-responders on 12 May 2014. Incoming survey data were entered into SPSS V19 software which was used for the analyses. Spearman correlation was used to assess the strength of association between levels reported for FoR and items from the Fear of Recurrence Questionnaire. The Chisquared test or Kruskal-Wallis test was used as appropriate to compare characteristics of patients within each FoR category, these being clinical and personal characteristics and also dysfunction, subscale scores and overall QOL pertaining to the the UW-QOL. Due to the number of tests performed, statistical significance was set at p \ 0.01.
Results
The survey response was 60 % (528/878), of which 513 completed the single-item question on FoR. Median (IQR) age at the time of first mailing for these 513 patients was 65 (58-72) years and 71 % (366) were male. The location of primary tumour was oral (35 %, 181), oropharyngeal (36 %, 185), laryngeal (20 %, 105) Responses to the new FoR question and to the seven items on the more established FoR questionnaire are Responses to the new FoR question showed strong association with many aspects of dysfunction as tapped into by studying UW-QOL domain scores and importance (Table 2) . Particularly strong were the associations with anxiety and mood dysfunction. Not unsurprisingly, there was therefore stronger discrimination with regard to the social-emotional subscale score than the physical subscale score. There was also a pronounced trend over FoR categories in the percentage reporting good, very good or outstanding overall quality of life.
Patients reporting more severe levels of FoR tended to be younger (Table 3 ). There were also significant associations with ever having had radiotherapy or chemotherapy as part of the head and neck cancer journey. Overall clinical staging of the primary tumour, primary tumour site and primary treatment showed little association with FoR, as did time from initial treatment or the age when patients finished formal education.
Discussion
Previous clinical outcome research has shown that FoR is the most common issue which head and neck cancer patients want to raise in the clinic [1, 3, 4] . High levels of FoR are strongly associated with low HRQOL [8] . FoR cannot be easily predicted by routine patient characteristics such as gender, site and stage [1, 4] . This was also reflected in this study, though patients reporting more severe levels of FoR tended to be younger, post-radiotherapy or [3] . However once identified, it would be helpful to gauge the degree of FoR concern and to include a single screening question bolted on to a well-established HRQOL would aid simplicity. The FoR screening question used in this study was developed in collaboration with patients and the multiprofessional team, but the census group was based just at one unit. There might be a need in future studies to assess cross-cultural variation in the wording used. The FoR question was assessed in a cross-sectional survey of survivors.
The cohort is open to survivorship bias with advance cancer being relatively underrepresented and also there is no longitudinal evaluation. The response rate of 60 % was acceptable for the purpose of correlation with another fear of recurrence measure. Using the new FoR question, a minority of patients (12 %) reported 'no fear of recurrence'. Nearly half reported 'having a little fear that did not really bother them'. The group where FoR was substantial were the 5 % reporting 'I am fearful all the time' and another 5 % reporting 'a lot of fears of recurrence and these can really pre-occupy my thought'. There was good correlation between items in the single questionnaire and the sevenquestion FoR scale (Fig. 2) . In addition, the correlation of this new UW-QOL item relates strongly to Item 1 of the FoR summative scale. This finding is an important concurrent validity. Hence, it would seem reasonable to suggest the choice of wording in the single UW-QOL style. FoR has reasonable validity to help grade severity and form a question that might help screen patients with FoR. These patients could have additional support and intervention. Where to set the cutoff will need further research using a larger sample and longitudinal data, but from this study it could be postulated that those patients scoring the worse two categories 'I am fearful all the time or a lot of fears of recurrence and these can really pre-occupy my thought', should be considered for added assessment and support.
There is an association between anxiety dysfunction as measured by the UW-QOL and FoR [1] . A cutoff for anxiety dysfunction has been defined for the UW-QOL [19] . However in the cohort sampled in this study, 16 participants (out of 53) who selected the two highest options of FoR in the screening question did not register as having anxiety dysfunction on the UWQOL. This suggests there is a place for an FoR question as one-third of patients within the two most severe categories would have been missed by the anxiety question alone. The middle option of the FoR screening question was selected by 144 patients, and 108 of these recorded fearful thoughts without anxiety being flagged up as a significant problem, showing that most of these patients with more moderate levels of FoR would be missed by the anxiety question alone. This supports the inclusion of a separate FoR question and its inclusion as part of patient-reported outcomes should enhance the clinic consultation [21] .
The new FoR question also correlated strongly with the social subscale of the UWQOL [19] suggesting that FoR is a relevant social problem within head and neck cancer. However, it also correlated to a lesser extent with the physical subscale of the UWQOL suggesting that FoR can be caused by both physical and social sources. This finding confirms that FoR can be linked to symptom experience. That is, patients with complaints about symptoms may think that they indicate a possible new disease process. This supports the Leventhal Self-Regulation Model. Alternatively it could mean that greater fears of recurrence magnify the reporting of other symptom complaints (i.e. reverse 'causation'). The correlation with overall quality of life score suggests this, in that patients overall well-being after cancer has an effect on FoR. These interpretations indicate an urgent need to explore longitudinal designs to test the causative processes involved.
This initial cross-sectional survey has shown that this single FoR question could have merit in the clinical care of head and neck cancer patients. Patients with FoR dysfunction can receive extra support and if required formal intervention focused on addressing FoR [15] . Further studies comparing the PCI and the screening question may also provide beneficial results to determine if those patients with FoR actually wish to discuss their problems. There is preliminary evidence that supports early intervention [21] as being most effective for FoR, so longitudinal evaluation of both screening for FoR and intervention is essential to help ascertain the optimal timing to support patients following completion of their cancer treatment.
Conclusion
The findings from this initial study show that the new FoR screening question may be suitable for inclusion in the UW-QOLv4. It would add little substantial questionnaire burden for patients. The inclusion of this question is potentially important as it will not only facilitate discussion in clinics concerning the issue of FoR, but also afford the opportunity for further outcomes research into the optimal intervention aimed at reducing FoR and improving the socio-emotional impact of cancer endured in patients during survivorship.
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